[1]DelRossi AJ,Cernaianu AC,Vertrees RA,et al.Platelet-rich plasma reduces postoperative blood loss after cardiopulmonary by pass.J Thorac Cardiovasc Surg. 1990; 100(2):281-286.[2]Ferrari M,Zia S,Valbonesi M,et al.A new technique for hemodilution, preparation of autologous platelet-rich plasma and intraoperative blood salvage in cardiac surgery.Int J Artif Organs.1987;10(1):47-50.[3]石晟,王古岩.术前自体血小板分离在心脏手术中的血液保护作用[J].中国分子心脏病学杂志,2015,15(2):1292-1294.[4]Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants.Int J Oral Maxillofac Implants.1999;14(4):529-535.[5]Nguyen RT,Borg-Stein J,McInnis K.Applications of platelet-rich plasma in musculoskeletal and sports medicine: an evidence-based approach. PM R.2011;3(3):226-250.[6]Mazzocca AD,McC'arthy MB,Chowaniec DM,et al. Platelet-rich plasma differs according to preparation method and human variability.J Bone Joint Surg Am. 2012;94: 308-316.[7]Cheung EV,Silverio L,Sperling JW.Strategies in biologic augmentation of rotator cuff repair: a review.Clin Orthop Relat Res.2010;468:1476-1484.[8]Malanga GA,Goldin M.PRP: review ofthe current evidence of the current evidence of musculoskeletal conditions.Curr Phys Med Rehab.2014;2(1):1-15.[9]Foster TE,Puskas BL,Mandelbaum BR,et al.Platelet-rich plasma: from basic science to clinical applications.Am J Sports Med.2009;37:2259-2272.[10]Boswell SG,Cole BJ,Sundman EA,et al.Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy.2012;28:429-439.[11]Barrientos S,Stojadinovic O,Golinko MS,et al.Growth factors and cytokines in wound healing. Wound Repair Regen. 2008; 16:585-601.[12]Scherer SS,Tobalem M,Vigato E,et al.Nonactivated versus thrombin-activated platelets on wound healing and fibroblast-myofibroblast differentiation in vivo and in vitro.Plas Reconstr Surg. 2012;129(1):46e-54e.[13]Geaney LE,Arciero RA,DeBarradino TM,et al.The effects of platelet-rich plasma on tendon and ligament: basic science and clinical application. Oper Tech Sports Med. 2011;19(3): 160-164.[14]Anitua E,Andia I,Sanchez M,et al.Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture.J Orthop Res.2005;23:281-286.[15]Zhou Y,Wang J.PRP treatment fficacy for tendinopathy: a review of basic science studies. Biomed Res Int. 2016;2016: 9103792. [16]Zhang J,Wang JH. Platelet-rich plasma releasate promotes differ-entiation of tendon stem cells into active tenocytes. AJSM.2010;38(12):2477-2486.[17]Chen L,Dong SW,Tao X,et al.Autologous platelet-rich clot releasate stimulates proliferation and inhibits differentiation of adult rat tendon stem cells towards nontenocyte lineages. J Int Med Res. 2012;40(4):1399-1409.[18]McCarrel T,Fortier L.Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. J Orthop Res.2009;27(8):1033-1042.[19]Intravia J,Allen DA,Durant TJS,et al.In vitro evaluation of the anti-bacterial effect of two preparations of platelet rich plasma compared with cefazolin and whole blood.Muscles Ligaments Tendons J.2014;4(1):79-84. [20]Madry H,Kohn D,Cucchiarini M.Direct FGF-2 gene transfer via recombinant adeno-associated virus vectors stimulates cell proliferation, collagen production, and the repair of experimental lesions in the human ACL.Am J Sports Med. 2013;41:194-202.[21]Marui T,Niyibizi C,Georgescu HI,et al.Effect of growth factors on matrix synthesis by ligament fibroblasts.J Orthop Res. 1997;15:18-23.[22]Hildebrand KA,Woo SLY, Smith DW, et al.The effects of platelet derived growth factor-BB on healing of the rabbit medial collateral ligament: an in vivo study.Am J Sports Med. 1998;26:549-554.[23]Batten ML,Hansen JC,Dahners LE,et al.Influence of dosage and timing of application of platelet derived growth factor on carly healing of the rat medial collateral ligament. J Orthop Res.1996;14:736-741.[24]Fleming BC,Spindler KP,Palmer MP,et al.Collagen-platelet composites improve the biomechanical properties of healing anterior cruciate ligament grafts in a porcine model.Am J Sports Med.2009;37:1554-1563.[25]Hak A, Rajaratnam K,Ayeni OR, et al. A double blinded placebo randomized controlled trial evaluating short-term efficacy of platelet-rich plasma in reducing postoperative pain after arthroscopic rotator cuff repair: a pilot study.Sports Health.2015;7(1):58-66.[26]Zhao JG,Zhao L,Jiang YX,et al.Platelet-rich plasma in arthroscopic rotator cuff repair: a meta- analysis of randomized controlled trials. Arthroscopy. 2015;31(1): 125-135.[27]Hurley ET,Lim Fat D,Moran CJ,et al.The efficacy of platelet-rich plasma and platelet-rich fibrin in arthroscopic rotator cuff repair: a meta-analysis of randomized controlled trials. Am J Sports Med. 2019;47(3):753-761. [28]Verhacgen F,Brys P,Debeer P.Rotator cuff healing ater needling of calcific deposit using platelet-rich plasma augmentation: a ran-domized, prospective clinical trial.J Shoulder Elb Surg.2016;25(2):169-173.[29]Carr A,Murphy R,Dakin S,et al.Plateltrich plasma injection with arthroscopic acriomioplasty for chronic rotator cuff tendinopathy.Am J Sports Med.2015;43(12):2891-2897.[30]Rha DW,Park GY,Kim YK,et al.Comparison ofthe therapeutic effects of ultrasound-guided platelet-rich plasma injection and dry needling in rotator cuff disease: a randomized controlled trial. Clin Rehab. 2013;27(2): 113-122.[31]Shams A,El-Sayed M,Gamal O,et al.Subacromial injection of autologous platelet-rich plasma versus corticosteroid for the treatment of symptomatic partial rotator cuff tears. Eur J Orthop Surg Traumatol. 2016;26(8):837-842.[32]Liddle AD,Rodriguez Merchan C.Platelet-rich plasma in the treatment of patellar tendinopathy: a systematic review.Am J Sports Med.2015;43(10):2583-2590.[33]Gosens T,Den Oudsten BL,Fievez E,et al. Pain and activity levels before and after platelet-rich plasma injection treatment of patellar tendinopathy: a prospective cohort study and the influence of previous treatments.Int Orthop. 2012;36(9): 1941-1946.[34]Zayni R,Thaunat M,Fayard JM,et al.Platelet-rich plasma as a treatment for chronic patellar tendinopathy: comparison of a single versus two consecutive injections.Muscles Ligaments Tendons J.2015;5(2):92-98.[35]Abate M, Di Carlo L,Verna S,et al.Synergistic activity of platelet rich plasma and high volume image guided injection for patellar tendinopathy.Knee Surg Sports Traumatol Arthrosc. 2018;26(12):3645-3651. [36]Filardo G, Kon E, Della Villa S,et al.Use of platelet-rich plasma for the treatment of refrac-tory jumper's knee.Int Orthop. 2010;34(6):909-915.[37]Kaux JF,Bruyere O,Croisier JL,et al.One-year follow-up of plate rich plasma infiltration to treat chronic proximal patellar tendinopathies.Acta Orthop Belg.2015;81:251-256.[38]Andriolo L,Altamura SA,Reale D,et al.Nonsurgical treatments of patellar tendinopathy: multiple injections of platelet-rich plasma are a suitable option: a systematic review and meta-analysis.Am J Sports Med. 2019;47(4): 1001-1018.[39]Cerellin M,de Girolamo L,Bait C,et al.Autologous plateletrich plasma gel to reduce donor-site morbidity after patellar tendon graft harvesting for anterior cruciate ligament reconstruction: a randomized, controlled clinical study. Knee Surg Sports Traumatol Arthrosc.2012;20(1):114-120.[40]Walters BL,Porter DA,Hobart SJ,et al.Effect of intraoperative platelet-rich plasma treatment on postoperative donor site knee pain in patellar tendon auto graft anterior cruciate ligament reconstruction: a double-blind randomized controlled trial.AJSM.2018;46(8):1827-1835.[41]Dayton P.Anatomic,vascular, and mechanical overview of the Achilles tendon. Clin Podiatr Med Surg.2017;34(2):107-113.[42]Benjamin M,Toumi H,Ralphs JR,et al.Where tendons and ligaments meet bone: attachment sites('entheses') in relation to exercise and/or mechanical load.J Anat. 2006;208(4): 471-490.[43]Di Matteo B,Kon GFE.Platelet-rich plasma: evidence for the treatment of patellar and Achilles tendinopathy -a systematic review.Musculoskelet Surg.2015;99(1):1-9.[44]de Vos RJ, Weir A, van Schie HT, Bierma-Zeinstra SM, et al. Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA. 2010;303(2):144-149.[45]Boesen AP, Hansen R, Boesen MI,et al.Effect of high-volume injection , platelet- rich plasma, and sham treatment in chronic midportion Achilles tendinopathy.Am J Sports Med. 2017; 45(9):2034-243.[46]Brummel J,Baker CL,Hopkins R,et al.Epicondylitis: lateral.Sports Med Arthrosc Rev. 2014;22(3):e1-6.[47]Ahmad Z,Siddiqui N,Malik SS,et al.Lateral epicondylitis: a review of pathology and management. Bone Joint J. 2013; 95-B(9):1158-1164. [48]Chen X,Jones IA,Park C,et al.The fficacy of platelet-rich plasma on tendon and ligament healing: a systematic review and meta -analysis with bias assessment. Am J Sports Med. 2018;46(8):2020-2032.[49]Mi B,Liu G,Zhou W,et al.Platelet rich plasma versus steroid on lateral epicondylitis: meta-analysis of randomized clinical trials.Phys Sports Med.2017;45(2):97-104. [50]Ben-Nafa W,Munro W.The ffect of corticosteroid versus platelet-rich plasma injection therapies for the management of lateral epicondylitis: a systematic review.SICOTJ.2018;4:11.[51]Mishra AK,Skrepnik NV,Edwards SG, et al. Efficacy of platelet-rich plasma for chronic tennis elbow: a double-blind, prospective, multicenter, randomized controlled trial of 230 patients. Am J Sports Med.2014;42(2):463-471.[52]Merolla G,Dellabiancia F,Ricci A,et al.Arthroscopic debridement versus platelet-rich plasma injection: a prospective, randomized, comparative study of chronic lateral epicondylitis with a nearly 2-year follow-up.Arthrosc J Arthrosc Relat Surg.2017;33(7):1320-1329.[53]Park SK,Choic YK,Kim HJ.Hypopigmentation and subcutancous fat, muscle, atrophy after local corticosteroid injection.KoreanI Anesthesiol.2013;65(6):59-61.[54]Clark NJ,Desai VS,Dines JD,et al.Nonrcconstruction options for treating medial ulnar collateral ligament injuries of the elbow in overhead athletes. Curr Rev Musculoskelet Med. 2018;11(1):48-54.[55]Podesta L,Crow SA,Volkmer D,et al.Treatment of partial ulnar collateral ligament tears in the elbow with platelet-rich plasma. Am J Sports Med.2013;41(7):1689-1694.[56]Hofiman JK,Protzman NM,Malhotra AD.Biologic augmentation of the ulnar collateral ligament in the elbow of a professional base-ball pitcher.Case Rep Orthop. 2015;2015: 130157.[57]Dines JS,Wiliams PN,ElAttrache N,et al.Platelet-rich plasma can be used to successfully treat elbow ulnar collateral ligament insufficency in high-level throwers.Am J Orthop. 2016;45(5):296-300.[58]Deal JB,Smith E,Heard W,et al.Platelet-rich plasma for primary treatment of partial ulnar collateral ligament tears: MRI correlation with results.Orthop J Sports Med. 2017; 5(11):2325967117738238.[59]Figueroa D,Figueroa F,Calvo R, et al. Platelet-rich plasma use in anterior cruciate ligament surgery: systematic review of the literature. J of Arth and Rel Surg.2015;31(5):981-988.[60]Mirzatolooei F,Alamdari MT,Khalkhali HR.The impact of platelet-rich plasma on the prevention of tunnel widening in ante-rior cruciate ligament reconstruction using quadrupled autologous hamstring tendon: a randomized clinical trial.Bone Joint J.2013;95-B(1):65-69.[61]Vadala A,Iorio R,De Carli A,et al.Platelet-rich plasma: docs it help reduce tunnel widening after ACL reconstruction? Knee Surg Sports Traumatol Arthrosc.2013;21(4):824-829.[62]Rupreht M,Vogrin M,Hussein M. MRI evaluation of tibial tunnel wall cortical bone formation after platelet-rich plasma applied during anterior cruciate ligament reconstruction. Radiol Oncol.2013;47(2):118-124.[63]Vogrin M,Rupreht M,Cmjac A,et al.The ffect of platelet-derived growth factors on knee stability after anterior cruciate ligament reconstruction: a prospective randomized clinical study. Wien Klin Wochenschrift.2010;122(S2):91-95.[64]Magnussen RA,Flanigan DC,Pedroza AD,et al.Platelet rich plasma use in allograft ACL reconstructions: two-year clinical results of a MOON cohort study.Knee.2013;20(4):277-280. [65]Di Mattco B,Loibl M,Andriolo L,et al. Biologic agents for anterior cruciate ligament healing: a systematic review.World J of Orthop.2016;7(9):592-603. |